RAPT Therapeutics Inc (NASDAQ: RAPT) open the trading on Wednesday, with a bit cautious approach as it glided -12.08% to $1.05, before settling in for the price of $1.20 at the close. Taking a more long-term approach, RAPT posted a 52-week range of $1.00-$27.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -36.87%. Meanwhile, its Annual Earning per share during the time was -12.39%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 18.23%. This publicly-traded company’s shares outstanding now amounts to $34.90 million, simultaneously with a float of $30.56 million. The organization now has a market capitalization sitting at $36.88 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7492, while the 200-day Moving Average is $4.2080.
RAPT Therapeutics Inc (RAPT) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. RAPT Therapeutics Inc’s current insider ownership accounts for 12.58%, in contrast to 75.05% institutional ownership. According to the most recent insider trade that took place on Jan 05 ’24, this organization’s CHIEF SCIENTIFIC OFFICER sold 898 shares at the rate of 22.78, making the entire transaction reach 20,456 in total value, affecting insider ownership by 27,820. Preceding that transaction, on Dec 21 ’23, Company’s Chief Medical Officer sold 2,500 for 21.68, making the whole transaction’s value amount to 54,200. This particular insider is now the holder of 15,020 in total.
RAPT Therapeutics Inc (RAPT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.
RAPT Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 18.23% and is forecasted to reach -1.58 in the upcoming year.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
Let’s observe the current performance indicators for RAPT Therapeutics Inc (RAPT). It’s Quick Ratio in the last reported quarter now stands at 9.90. The Stock has managed to achieve an average true range (ATR) of 0.22.
In the same vein, RAPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.78, a figure that is expected to reach -0.45 in the next quarter, and analysts are predicting that it will be -1.58 at the market close of one year from today.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
[RAPT Therapeutics Inc, RAPT] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 48.90% While, its Average True Range was 0.1894.
Raw Stochastic average of RAPT Therapeutics Inc (RAPT) in the period of the previous 100 days is set at 1.95%, which indicates a major fall in contrast to 9.24% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 126.18% that was lower than 128.74% volatility it exhibited in the past 100-days period.
